250 Consumers Rd. Unit 511, North York, ON M2J 4V6 4164772877, 6474287217
Lily Lee President
Discount Travel & Tours Inc Travel Agency
437 State Rte 10, Whippany, NJ 07981 9738875158
Lily Lee Owner
Lily's Beauty Salon Beauty Shop
5315 Lincoln Ave, Skokie, IL 60077
Lily Lee Director
Job51.ca Human Resources · Employment Service
4164772877, 6474287217
Lily Lee Assistant
City of Los Angeles General Government · Administrative Educational Programs · Legal Services Office · Fire Protection · Individual/Family Services · Public Finance/Taxation/Monetary Policy · Police Protection · City Attorney's Office
2136233473, 2134858971, 2134853563, 8187568615
Lily Lee Principal
Windsor Insurance Brokerage Fi Insurance Agent/Broker
50 Princtn Hightstwn N, W Windsor Township, NJ 08550
Lily Lee Principal
Dacare Staffing Help Supply Services
1451 Brittania Way, Keeneyville, IL 60172
Lily Lee Account Manager
3 Win, Inc Local Trucking Operator
290 Nye Ave, Irvington, NJ 07111 9733998696
Us Patents
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K031/336 A61K038/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating a parasitic infection, a lymphoid malignancy or an autoimmune disorder in a subject by administering to the subject a therapeutically effective amount of an angiogenesis inhibitor compound comprising a MetAP-2 inhibitory core coupled to a peptide.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
Methionine Aminopeptidase-2 Inhibitors And Methods Of Use Thereof
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating, parasitic infections, thymoma, and lymphoid malignancies in a subject by administering to the subject a therapeutically effective amount of one or more of the compounds of the invention.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating an autoimmune disorder (e. g. , lupus erythematosus, multiple sclerosis, myasthenia gravis, vasculitis and diabetes mellitus) in a subject by administering to the subject a therapeutically effective amount of one or more compounds of the invention.
Methionine Aminopeptidase-2 Inhibitors And Methods Of Use Thereof
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - New York NY, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals Incorporated - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating a lymphoma (e. g. , a T-cell lymphoma or a B-cell lymphoma) in a subject by administering to the subject a therapeutically effective amount of one or more of the compounds of the invention, for example, compounds of formulae I and XV:.
Therapeutic Agents And Methods Of Use Thereof For The Treatment Of Melanoma
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - New York NY, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
Substituted Phenyl Acetamides And Their Use As Protease Inhibitors
Kevin D. Kreutter - Plainsboro NJ, US Lily Lee - New York NY, US Tianbao Lu - Churchville PA, US Venkatraman Mohan - Plainsboro NJ, US Sharmila Patel - Jamison PA, US Hui Huang - Monroe NJ, US Guozhang Xu - Langhorne PA, US Mark Fitzgerald - Atco NJ, US
Assignee:
Johnson & Johnson Pharmaceuticals Research & Development, L.L.C. - Raritan NJ
Dr. Lee graduated from the Southern Illinois University School of Medicine in 1994. She works in Campbell, CA and specializes in Internal Medicine. Dr. Lee is affiliated with Kaiser Permanente Santa Clara Medical Center.
Dr. Lee graduated from the Saint Louis University School of Medicine in 1998. She works in Manhattan Beach, CA and 1 other location and specializes in Obstetrics & Gynecology. Dr. Lee is affiliated with Cedars-Sinai Medical Center.
The Manayunk Diner at the bottom of Main Street was also open "Koreans never close for anything," said Lily Lee, the owner's daughter but business was slow. Benjamin Kall came in for what might be that last "nice, full breakfast" for a while.